Skip to main content

Hypoactive Sexual Desire Disorder

1
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Peptide
2100%
+ 2 programs with unclassified modality

Competitive Landscape

3 companies ranked by most advanced pipeline stage

VIVUS
VIVUSCA - Campbell
1 program
1
Testosterone Spray 5% and 1%Phase 11 trial
Active Trials
NCT01096329Terminated16
Palatin Technologies
2 programs
BremelanotidePHASE_3Peptide1 trial
BremelanotidePHASE_3Peptide1 trial
Active Trials
NCT02338960Completed714Est. Jun 2017
NCT02333071Completed723Est. Jun 2017
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Expressive writingN/A1 trial
Active Trials
NCT01803802Completed148Est. Aug 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Palatin TechnologiesBremelanotide
Palatin TechnologiesBremelanotide
VIVUSTestosterone Spray 5% and 1%
Human BioSciencesExpressive writing

Clinical Trials (4)

Total enrollment: 1,601 patients across 4 trials

NCT02338960Palatin TechnologiesBremelanotide

2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder

Start: Jan 2015Est. completion: Jun 2017714 patients
Phase 3Completed
NCT02333071Palatin TechnologiesBremelanotide

1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder

Start: Dec 2014Est. completion: Jun 2017723 patients
Phase 3Completed
NCT01096329VIVUSTestosterone Spray 5% and 1%

A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa®

Start: Feb 201016 patients
Phase 1Terminated
NCT01803802Human BioSciencesExpressive writing

Effects of Early Abuse on Adult Intimate Relationships

Start: Apr 2005Est. completion: Aug 2014148 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.